These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1719266)

  • 1. Effects of hemodialysis on platelet-derived thrombospondin.
    Gawaz MP; Ward RA
    Kidney Int; 1991 Aug; 40(2):257-65. PubMed ID: 1719266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble P-selectin is released from activated platelets in vivo during hemodialysis.
    Kawabata K; Nagake Y; Shikata K; Fukuda S; Nakazono H; Takahashi M; Ichikawa H; Makino H
    Nephron; 1998; 78(2):148-55. PubMed ID: 9496730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma thrombospondin in patients with chronic renal failure, liver disease and splenectomy.
    Trzeciak MC; McGregor J; Renaux JL; Ville D; Berruyer M; Dawes J; Dechavanne M
    Thromb Res; 1985 Oct; 40(1):121-8. PubMed ID: 3003959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma thrombospondin as an indicator of intravascular platelet activation in patients with vasculitis.
    McCrohan MB; Huang SW; Sleasman JW; Klein PA; Kao KJ
    Thromb Haemost; 1987 Oct; 58(3):850-2. PubMed ID: 2963403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis-associated platelet activation and thrombocytopenia.
    Hakim RM; Schafer AI
    Am J Med; 1985 Apr; 78(4):575-80. PubMed ID: 3885730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activation markers in patients with nephrotic syndrome. A comparative study of different platelet function tests.
    Sirolli V; Ballone E; Garofalo D; Merciaro G; Settefrati N; Di Mascio R; Di Gregorio P; Bonomini M
    Nephron; 2002 Jul; 91(3):424-30. PubMed ID: 12119472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
    Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
    Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do extra-platelet sources contribute to the plasma level of thrombospondin?
    Dawes J; Pratt DA; Dewar MS; Preston FE
    Thromb Haemost; 1988 Apr; 59(2):273-6. PubMed ID: 2968680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activation during hemodialysis measured through exposure of p-selectin: analysis by flow cytometric and ultrastructural techniques.
    Reverter JC; Escolar G; Sanz C; Cases A; Villamor N; Nieuwenhuis HK; López J; Ordinas A
    J Lab Clin Med; 1994 Jul; 124(1):79-85. PubMed ID: 7518492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Observation of platelet activation in coronary heart disease].
    Li FG; Wu GX; Li PX
    Zhonghua Nei Ke Za Zhi; 1993 Jan; 32(1):17-20. PubMed ID: 7691488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay of human platelet thrombospondin: different patterns of thrombospondin and beta-thromboglobulin antigen secretion and clearance from the circulation.
    Switalska HI; Niewiarowski S; Tuszynski GP; Rucinski B; Schmaier AH; Morinelli TA; Cierniewski CS
    J Lab Clin Med; 1985 Dec; 106(6):690-700. PubMed ID: 2415646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment.
    Valles J; Santos MT; Aznar J; Marcus AJ; Martinez-Sales V; Portoles M; Broekman MJ; Safier LB
    Blood; 1991 Jul; 78(1):154-62. PubMed ID: 1712639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet GPIIb/IIIa is activated and platelet-leukocyte coaggregates formed in vivo during hemodialysis.
    Kawabata K; Nakai S; Miwa M; Sugiura T; Otsuka Y; Shinzato T; Hiki Y; Tomimatsu I; Ushida Y; Hosono F; Maeda K
    Nephron; 2002 Apr; 90(4):391-400. PubMed ID: 11961397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro thromboxane synthesis of depleted blood platelets following renal transplantation.
    Scharf RE
    Thromb Haemost; 1990 Aug; 64(1):161-4. PubMed ID: 2148845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD62, thromboxane B2, and beta-thromboglobulin: a comparison between different markers of platelet activation after contact with biomaterials.
    Cenni E; Granchi D; Verri E; Cavedagna D; Gamberini S; Falsone G; Pizzoferrato A
    J Biomed Mater Res; 1997 Sep; 36(3):289-94. PubMed ID: 9260099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in platelet membrane glycoproteins and platelet-leukocyte interaction during hemodialysis.
    Gawaz M; Bogner C
    Clin Investig; 1994 Jun; 72(6):424-9. PubMed ID: 7524831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dialyzer geometry during hemodialysis with cuprophane membranes.
    Taylor JE; McLaren M; Mactier RA; Henderson IS; Stewart WK; Belch JJ
    Kidney Int; 1992 Aug; 42(2):442-7. PubMed ID: 1405328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of methods for evaluating exercise-induced changes in thromboxane B2 and beta-thromboglobulin.
    Todd MK; Goldfarb AH; Burleson C
    Med Sci Sports Exerc; 1997 May; 29(5):700-4. PubMed ID: 9140910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activation during preparation of platelet concentrates: a comparison of the platelet-rich plasma and the buffy coat methods.
    Fijnheer R; Pietersz RN; de Korte D; Gouwerok CW; Dekker WJ; Reesink HW; Roos D
    Transfusion; 1990 Sep; 30(7):634-8. PubMed ID: 2144922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activation on hemodialysis: influence of dialysis membranes.
    Cases A; Reverter JC; Escolar G; Sanz C; Lopez-Pedret J; Revert L; Ordinas A
    Kidney Int Suppl; 1993 Jun; 41():S217-20. PubMed ID: 8320925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.